SR146131 is a new potent, orally bioavailable, and selective nonpeptide cholecystokinin subtype 1 receptor agonist on IMR-32 human neuroblastoma cells. References: Shilling PD, Feifel D. SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI. Psychopharmacology (Berl). 2002 Nov;164(3):285-93. Epub 2002 Sep 4. PubMed PMID: 12424552.

纯度：≥98%

CAS：221671-61-0